AposHealth Awarded Research Grant to Rebuild After COVID-19
AposHealth (formerly AposTherapy), a provider of solutions for gait-related conditions, announces that its UK division has won a £266,555 research grant from Innovate UK, a part of UK Research and Innovation, to help address the effects of COVID-19.
AposHealth UK partnered with Vitrue Health, a musculoskeletal health diagnostics startup, to answer Innovate UK’s call for proposals to help all sectors of the country rebuild after the COVID-19 crisis.
“Patients with mobility issues now face more barriers to care than ever. We’re excited to collaborate with Vitrue Health and Innovate UK to develop the advanced technologies that will make it possible for this unique population to access non-invasive gait treatments from the comfort and safety of their own homes.”